Clinical significance of ras p21 overexpression for patients with an advanced colorectal cancer.

The expression of ras oncogene product p21 was examined in 45 paraffin-embedded sections of primary advanced colorectal cancers, using the anti-v-H-ras p21 monoclonal antibody Y13-259. Fourteen of these specimens (31 percent) were stained positively. The incidence of lymphatic vessel invasion of cancer cells and lymph node metastasis correlated statistically with the overexpression of ras p21. The depth of invasion and incidence of liver metastasis in the p21-positive group were more prominent than in the p21-negative group. Statistically significant differences were evident in operative curability and clinical stage at initial surgery and in the long-term survival rate between these groups (P less than 0.05). We propose that ras p21 overexpression may serve as a marker to predict the prognosis of colorectal cancer.
AuthorsM Miyahara, T Saito, K Kaketani, K Sato, A Kuwahara, K Shimoda, M Kobayashi
JournalDiseases of the colon and rectum (Dis Colon Rectum) Vol. 34 Issue 12 Pg. 1097-102 (Dec 1991) ISSN: 0012-3706 [Print] UNITED STATES
PMID1959459 (Publication Type: Journal Article)
  • Adult
  • Aged
  • Aged, 80 and over
  • Colonic Neoplasms (genetics, mortality, pathology)
  • Female
  • Genes, ras (physiology)
  • Humans
  • Immunoenzyme Techniques
  • Male
  • Middle Aged
  • Neoplasm Invasiveness
  • Neoplasm Metastasis
  • Neoplasm Staging
  • Prognosis
  • Rectal Neoplasms (genetics, mortality, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: